Nasdaq:US$13.42 (-0.18) | HKEX:HK$21.48 (+0.42) | AIM:£2.04 (+0.07)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF